1. Home
  2. VSAT vs NVAX Comparison

VSAT vs NVAX Comparison

Compare VSAT & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ViaSat Inc.

VSAT

ViaSat Inc.

HOLD

Current Price

$32.27

Market Cap

4.8B

Sector

Technology

ML Signal

HOLD

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$6.69

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VSAT
NVAX
Founded
1986
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8B
1.1B
IPO Year
1996
1995

Fundamental Metrics

Financial Performance
Metric
VSAT
NVAX
Price
$32.27
$6.69
Analyst Decision
Buy
Hold
Analyst Count
7
9
Target Price
$33.00
$10.78
AVG Volume (30 Days)
1.7M
3.3M
Earning Date
02-05-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.07
Revenue
$4,582,796,000.00
$1,064,651,000.00
Revenue This Year
$5.21
$58.91
Revenue Next Year
$3.22
N/A
P/E Ratio
N/A
$3.15
Revenue Growth
1.23
20.27
52 Week Low
$7.36
$5.01
52 Week High
$43.59
$11.55

Technical Indicators

Market Signals
Indicator
VSAT
NVAX
Relative Strength Index (RSI) 42.12 43.66
Support Level $32.08 $6.36
Resistance Level $38.66 $6.76
Average True Range (ATR) 1.91 0.22
MACD -0.28 0.04
Stochastic Oscillator 5.32 48.89

Price Performance

Historical Comparison
VSAT
NVAX

About VSAT ViaSat Inc.

Viasat Inc provides bandwidth technologies and services in three segments: communication services and defense and advanced technologies. The communication services segment provides a wide range of broadband and narrowband communications solutions across government and commercial mobility markets, as well as for residential and enterprise fixed broadband customers: and the defense and advanced technologies segment develops and offers a diverse array of resilient, vertically integrated solutions to government and commercial customers, leveraging core technical competencies in encryption, cyber security, tactical gateways, modems and waveforms. A large majority of the firm's revenue is generated from communication services segment.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Share on Social Networks: